Patents by Inventor Fabrice Viviani

Fabrice Viviani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrimidooxazocine derivatives as mTOR-inhibitors
    Patent number: 9120812
    Abstract: The invention relates to bicyclic heterocyclic derivatives of general formula (I) to a process for preparing them and to the therapeutic use thereof.
    Type: Grant
    Filed: January 25, 2013
    Date of Patent: September 1, 2015
    Assignee: Sanofi
    Inventors: Alain Braun, Olivier Crespin, Yann Foricher, Gilbert Marciniak, Nicolas Muzet, Eric Nicolai, Cecile Pascal, Bertrand Vivet, Fabrice Viviani
  • PYRIMIDOOXAZOCINE DERIVATIVES AS MTOR - INHIBITORS
    Publication number: 20140378433
    Abstract: The invention relates to bicydic heterocyclic derivatives of general formula (I) to a process for preparing them and to the therapeutic use thereof.
    Type: Application
    Filed: January 25, 2013
    Publication date: December 25, 2014
    Applicant: SANOFI
    Inventors: Alain Braun, Olivier Crespin, Yann Foricher, Gilbert Marciniak, Nicolas Muzet, Eric Nicolai, Cecile Pascal, Bertrand Vivet, Fabrice Viviani
  • 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
    Patent number: 8846670
    Abstract: The invention relates to compounds of the formula: or their racemic, enantiomeric or diastereoisomeric isomers, or pharmaceutically acceptable salts of the compounds of formula I or the racemic, enantiomeric or diasteroisomeric isomers.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: September 30, 2014
    Assignee: Sanofi
    Inventors: Eric Bacque, Maurice Brollo, Annie Clauss, Youssef El Ahmad, Bruno Filoche-Romme, Frank Halley, Karl Andreas Karlsson, Gilbert Marciniak, Baptiste Ronan, Laurent Schio, Bertrand Vivet, Fabrice Viviani, Andre Zimmermann
  • Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
    Patent number: 8846654
    Abstract: A subject-matter of the present invention is the use of compounds of formula (I) in the base, hydrate or solvate form or in the form of their mixtures, as medicaments or for the preparation of medicaments intended for the treatment of at least one cardiovascular disease and/or to prevent the appearance of at least one cardiovascular disease.
    Type: Grant
    Filed: October 7, 2011
    Date of Patent: September 30, 2014
    Assignee: Sanofi
    Inventors: Philip Janiak, Gilbert Marciniak, Jean-Francois Nave, Fabrice Viviani
  • 2,3-dihydro-1H-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof
    Patent number: 8828997
    Abstract: The invention relates to a product of formula (I) where R1, R2, R3, and R4 are as defined herein, the therapeutic use of the product, a process to make the product, and a pharmaceutical composition comprising the product.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: September 9, 2014
    Assignee: Sanofi
    Inventors: Maurice Brollo, Annie Clauss, Youssef El Ahmad, Bruno Filoche-Romme, Frank Halley, Karl Andreas Karlsson, Gilbert Marciniak, Baptiste Ronan, Laurent Schio, Bertrand Vivet, Fabrice Viviani, Andre Zimmermann
  • Therapeutic uses of quinazolinedione derivatives
    Patent number: 8748441
    Abstract: The subject matter of the present invention is the use of compounds of formula (I) in the form of a base, a hydrate or a solvate, or of mixtures thereof, as a medicament or for preparing a medicament intended for the treatment and/or prevention of disorders associated with the central nervous system (abbreviated to CNS) and/or associated with the peripheral nervous system (abbreviated to PNS).
    Type: Grant
    Filed: March 25, 2010
    Date of Patent: June 10, 2014
    Assignee: SANOFI
    Inventors: Gilbert Marciniak, Jean-Francois Nave, Fabrice Viviani
  • NOVEL 1,2,3,4-TETRAHYDRO-PYRIMIDO(1,2-A)PYRIMIDIN-6-ONE DERIVATIVES, PREPARATION THEREOF, AND PHARMACEUTICAL USE THEREOF
    Publication number: 20120208810
    Abstract: The invention relates to the novel materials of formula (I), where: R1 is an optionally substituted L-aryl or L-heteroaryl, such that L is a single bond, alkyl, CO, or CO-alk, or L-X, with L? being an alkyl and X being O or S; R2 is H or alkyl; R3 is an alkyl optionally substituted by Hal; and R4 is Hou Hal, wherein said materials are in any isomeric form and the salts thereof, to be used as drugs.
    Type: Application
    Filed: July 1, 2010
    Publication date: August 16, 2012
    Applicant: SANOFI
    Inventors: Eric Bacque, Maurice Brollo, Annie Clauss, Youssef El Ahmad, Bruno Filoche-Romme, Frank Halley, Karl Andreas Karlsson, Gilbert Marciniak, Baptiste Ronan, Laurent Schio, Bertrand Vivet, Fabrice Viviani, Andre Zimmermann
  • THERAPEUTIC APPLICATIONS IN THE CARDIOVASCULAR FIELD OF QUINAZOLINEDIONE DERIVATIVES
    Publication number: 20120184522
    Abstract: A subject-matter of the present invention is the use of compounds of formula (I) in the base, hydrate or solvate form or in the form of their mixtures, as medicaments or for the preparation of medicaments intended for the treatment of at least one cardiovascular disease and/or to prevent the appearance of at least one cardiovascular disease.
    Type: Application
    Filed: October 7, 2011
    Publication date: July 19, 2012
    Applicant: SANOFI
    Inventors: Philip JANIAK, Gilbert MARCINIAK, Jean-Francois NAVE, Fabrice VIVIANI
  • NOVEL 2,3-DIHYDRO-1H-IMIDAZO(1,2-A)PYRIMIDIN-5-ONE DERIVATIVES, PREPARATION THEREOF, AND PHARMACEUTICAL USE THEREOF
    Publication number: 20120142679
    Abstract: The invention relates to the novel materials of formula (I), where R1 is an optionally substituted L-aryl or -heteroaryl, such that L is: an alkyl or CO, or LX, with Lbeing an alkyl and X being O or S; R2 is H or an alkyl; R3 is an alkyl optionally substituted by Hal; and R4 is Hou Hal, wherein said materials are in any isomeric form and the salts thereof, to be used as drugs.
    Type: Application
    Filed: July 1, 2010
    Publication date: June 7, 2012
    Applicant: SANOFI
    Inventors: Maurice Brolio, Annie Clauss, Youssef El Ahmad, Bruno Filoche-Romme, Frank Halley, Karl Andreas Karlsson, Gilbert Marciniak, Baptiste Ronan, Laurent Schio, Bertrand Vivet, Fabrice Viviani, Andre Zimmermann
  • THERAPEUTIC USES OF QUINAZOLINEDIONE DERIVATIVES
    Publication number: 20120058987
    Abstract: The subject matter of the present invention is the use of compounds of formula (I) in the form of a base, a hydrate or a solvate, or of mixtures thereof, as a medicament or for preparing a medicament intended for the treatment and/or prevention of disorders associated with the central nervous system (abbreviated to CNS) and/or associated with the peripheral nervous system (abbreviated to PNS).
    Type: Application
    Filed: March 25, 2010
    Publication date: March 8, 2012
    Applicant: SANOFI
    Inventors: Gilbert Marciniak, Jean-Francois Nave, Fabrice Viviani
  • 7-substituted aza-indazoles, compositions containing same, production method and use thereof
    Patent number: 8058290
    Abstract: The disclosure relates to compounds of formula (I): which modulate the activity of proteins, particularly kinases, and to compositions containing the same, and to the use thereof as medicaments, in particular as anticancer agents.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: November 15, 2011
    Assignee: Aventis Pharma S.A.
    Inventors: Kirsten Bjergarde, Anil Nair, Marcel Patek, Martha Ackerman-Berrier, Martin Smrcina, Eric Bacque, Michel Tabart, Baptiste Ronan, Vincent Leroy, Fabrice Viviani, Mark Dodson, Catherine Souaille
  • Substituted pyrazolopyridines, compositions containing them, method for the production thereof, and their use
    Patent number: 8008322
    Abstract: The disclosure relates to substituted pyrazolo-pyridines, compositions containing them, methods for the production thereof, and to their use as medicaments, in particular, as anticancer agents.
    Type: Grant
    Filed: July 17, 2007
    Date of Patent: August 30, 2011
    Assignee: Aventis Pharma S.A.
    Inventors: Baptiste Ronan, Michel Tabart, Frank Halley, Eric Bacque, Catherine Souaille, Antonio Ugolini, Fabrice Viviani
  • SUBSTITUTED PYRAZOLOPYRIDINES, COMPOSITIONS CONTAINING THEM, METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE
    Publication number: 20110190337
    Abstract: The disclosure relates to substituted pyrazolo-pyridines, compositions containing them, methods for the production thereof, and to their use as medicaments, in particular, as anticancer agents.
    Type: Application
    Filed: April 11, 2011
    Publication date: August 4, 2011
    Applicant: AVENTIS PHARMA S.A..
    Inventors: Baptiste RONAN, Michel TABART, Frank HALLEY, Eric BACQUE, Catherine SOUAILLE, Antonio UGOLINI, Fabrice VIVIANI
  • Substituted pyrrolopyridines, compositions containing them, manufacturing process therefor and use thereof
    Patent number: 7947706
    Abstract: The invention relates to compounds of formula (I): wherein Ra, R1, Ar, L, A, W, Y, and Z are as defined in the disclosure; to compositions containing them; and to the preparation and use thereof, in particular as anticancer agents.
    Type: Grant
    Filed: October 11, 2007
    Date of Patent: May 24, 2011
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Michel Tabart, Eric Bacque, Frank Halley, Baptiste Ronan, Pascal Desmazeau, Fabrice Viviani, Catherine Souaille
  • Substituted pyrroles, compositions containing same, method for making same and use thereof
    Patent number: 7592365
    Abstract: The disclosure concerns substituted pyrroles of formula (I): wherein A, L, Ar, R1, R2, R5, and Ra are as defined in the disclosure, compositions containing the same, methods for making the same and uses thereof, in particular as anti-cancer agents.
    Type: Grant
    Filed: August 1, 2007
    Date of Patent: September 22, 2009
    Assignee: Aventis Pharma S.A.
    Inventors: Baptiste Ronan, Michel Tabart, Catherine Souaille, Fabrice Viviani, Eric Bacque, Jean-Philippe Letallec, Pascal Desmazeau
  • Substituted indoles, compositions containing them, method for the production thereof and their use
    Patent number: 7566736
    Abstract: Compounds of formula (I): wherein R1, R5, R6, R7, Ar, L, A, and Q are as defined in the description, and to salts thereof, to compositions containing them, to the process for preparing them, and to their use as medicinal products, in particular as anticancer agents.
    Type: Grant
    Filed: June 4, 2007
    Date of Patent: July 28, 2009
    Assignee: Aventis Pharma S.A.
    Inventors: Frank Halley, Catherine Souaille, Michel Tabart, Eric Bacque, Fabrice Viviani, Baptiste Ronan, Jean-Philippe Letallec, Bruno Filoche-Rommé
  • Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof
    Patent number: 7560571
    Abstract: The disclosure concerns substituted imidazoles and pyrroles, compositions containing the same, the preparation thereof, and the use thereof as medicaments, particularly as anti-cancer agents.
    Type: Grant
    Filed: August 1, 2007
    Date of Patent: July 14, 2009
    Assignee: Aventis Pharma S.A.
    Inventors: Baptiste Ronan, Frank Halley, Catherine Souaille, Fabrice Viviani, Youssef El-Ahmad, Eric Bacque, Michel Tabart
  • Substituted indazoles, compositions containing the same, and the preparation and use thereof
    Patent number: 7517902
    Abstract: Disclosed are novel substituted indazole compounds, pharmaceutical compositions comprising such compounds, and methods of treatment comprising such compounds.
    Type: Grant
    Filed: December 4, 2006
    Date of Patent: April 14, 2009
    Assignee: Aventis Pharma S.A.
    Inventors: Frank Halley, Michel Tabart, Hervé Bouchard, Catherine Souaille, Alain Le Brun, Fabrice Viviani, Laurence Gauzy-Lazo, Pascal Desmazeau, Odile Angouillant-Boniface, Bruno Filoche-Romme
  • Substituted tetrahydro-1-pyrazolo [3,4-]pyridines compositions comprising them, and use
    Patent number: 7435820
    Abstract: Substituted tetrahydro-1H-pyrazolo[3,4-c]pyridines, compositions comprising them and use. The present invention relates in particular to novel substituted tetrahydro-1H-pyrazolo[3,4-c]pyridines having therapeutic activity, which can be used in particular in oncology.
    Type: Grant
    Filed: May 23, 2006
    Date of Patent: October 14, 2008
    Assignee: Aventis Pharma S.A.
    Inventors: Fabienne Thompson, Catherine Souaille, Fabrice Viviani, Michel Tabart, Patrick Mailliet, Teresa Damiano, Marie-Pierre Cherrier, Francois Clerc, Frank Halley, Herve Bouchard, Laurence Gauzy-Lazo, Bernard Baudoin
  • 7-Substituted Aza-Indazoles, Compositions Containing Same, Production Method and Use Thereof
    Publication number: 20080182844
    Abstract: The disclosure relates to compounds of formula (I): which modulate the activity of proteins, particularly kinases, and to compositions containing the same, and to the use thereof as medicaments, in particular as anticancer agents.
    Type: Application
    Filed: January 29, 2008
    Publication date: July 31, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Kirsten BJERGARDE, Anil NAIR, Marcel PATEK, Martha ACKERMAN-BERRIER, Martin SMRCINA, Eric BACQUE, Michel TABART, Baptiste RONAN, Vincent LEROY, Fabrice VIVIANI, Mark DODSON, Catherine SOUAILLE